Table 6.
Top ten most consumed oral antibiotics in public hospitals in Myanmar (2014 to 2017).
| Hospital | |||||
|---|---|---|---|---|---|
| <200 beds | ≥200 beds | Central | |||
| Antibiotic Substance | Proportion | Antibiotic Substance | Proportion | Antibiotic Substance | Proportion |
| Combinations of penicillins (J01CR50) | 16.4 | Azithromycin (J01FA10) | 15.1 | Amoxicillin and enzyme inhibitor (J01CR02) | 19.8 |
| Azithromycin (J01FA10) | 11.3 | Cefixime (J01DD08) | 14.0 | Cefixime (J01DD08) | 19.2 |
| Cefalexin (J01DB01) | 10.7 | Combinations of penicillins (J01CR50) | 11.5 | Levofloxacin (J01MA12) | 14.4 |
| Cefixime (J01DD08) | 10.5 | Amoxicillin (J01CA04) | 11.4 | Azithromycin (J01FA10) | 10.4 |
| Ciprofloxacin (J01MA02) | 9.5 | Amoxicillin and enzyme inhibitor (J01CR02) | 7.9 | Cefuroxime (J01DC02) | 5.2 |
| Amoxicillin (J01CA04) | 8.9 | Ciprofloxacin (J01MA02) | 6.8 | Cefalexin (J01DB01) | 4.6 |
| Doxycycline (J01AA02) | 6.2 | Levofloxacin (J01MA12) | 6.5 | Amoxicillin (J01CA04) | 4.5 |
| Sulfamethoxazole and trimethoprim (J01EE01) | 4.9 | Cefalexin (J01DB01) | 4.5 | Doxycycline (J01AA02) | 3.8 |
| Norfloxacin (J01MA06) | 4.7 | Metronidazole (P01AB01) | 4.3 | Ciprofloxacin (J01MA02) | 3.7 |
| Amoxicillin and enzyme inhibitor (J01CR02) | 3.7 | Doxycycline (J01AA02) | 3.7 | Ofloxacin (J01MA01) | 2.3 |